Triolein-d5
Triolein-d5 is the deuterium labeled Triolein. Triolein is a symmetrical triacylglycerol, reduces MMP-1 upregulation, with strong antioxidant and anti-inflammatory properties[1].
Product Specifications
CAS Number
60892-83-3
UNSPSC
12352211
Hazard Statement
H225
Target
Endogenous Metabolite; Isotope-Labeled Compounds; MMP
Type
Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease; Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Inflammation/Immunology
Purity
97.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
[2H]C([2H])(OC(CCCCCCC/C=C\CCCCCCCC)=O)C([2H])(OC(CCCCCCC/C=C\CCCCCCCC)=O)C([2H])(OC(CCCCCCC/C=C\CCCCCCCC)=O)[2H]
Molecular Formula
C57H99D5O6
Molecular Weight
890.46
Precautions
H225
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Leirós GJ, et al. Triolein reduces MMP-1 upregulation in dermal fibroblasts generated by ROS production in UVB-irradiated keratinocytes. J Dermatol Sci. 2017 Feb;85 (2) :124-130.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CY533-AH 3 µm
Caprisil NH2-H HPLC Column, 3 µm, 100 Å, CY533-AH x 75 mm
Sign In for Pricing
View Details 
MBS1311102-01 0.02 mg (E-Coli)
Recombinant Xenopus laevis THAP domain-containing protein 1 A (thap1-a)
Sign In for Pricing
View Details